Sign in to continue:

Saturday, February 7th, 2026
IPO

Beijing Haizhi Technology Group Co., Ltd. Announces Hong Kong Listing Update and Investor Guidance 1

Beijing Haizhi Technology Group Co., Ltd. IPO Analysis: Key Data, Risks, and Outlook

Company: Beijing Haizhi Technology Group Co., Ltd.

Date of Prospectus: December 22, 2025

Beijing Haizhi Technology Group IPO: Everything Investors Need to Know Before Listing Day

Beijing Haizhi Technology Group Co., Ltd. is preparing for a public listing on the Hong Kong Stock Exchange, offering investors a unique opportunity to participate in the growth of a leading technology firm in China. This article delivers a comprehensive, data-driven analysis of the IPO structure, financials, management, and sector outlook, strictly based on the company’s official disclosures. Investors will find all essential details for making an informed decision, from offer breakdown and use of proceeds to risk factors and expected first-day performance.

IPO Snapshot: Key Details for Investors

Beijing Haizhi Technology Group Co., Ltd. is seeking to list its shares in Hong Kong. This initial public offering is designed to provide both institutional and retail investors with access to one of China’s recognized technology firms.

  • IPO Symbol: Not disclosed
  • Offer Price / Price Range: Not disclosed
  • Total Offer Size: Not disclosed
  • Number of Shares Offered: Not disclosed
  • Post-IPO Outstanding Shares: Not disclosed
  • Dividend Policy: Not disclosed
  • Offer Period / Timetable: Prospectus dated December 22, 2025; application approval and listing date not yet confirmed [[3]].
  • Placement Breakdown: Not disclosed

Key Note: There is no guarantee that the offering will proceed, and all investment decisions should be based on the final prospectus registered with the Registrar of Companies in Hong Kong [[1]][[2]][[3]].

Investor Participation and Book Quality

The involvement of reputable coordinators signals an institutional-grade offering process. The following firms have been appointed as overall coordinators:

  • CMB International Capital Limited
  • BOCI Asia Limited
  • Shenwan Hongyuan Securities (H.K.) Limited

Anchor investors, subscription levels, and book quality metrics have not been disclosed in the announcement. There is no information on pre-listing disposals or sales by existing shareholders. The presence of leading investment banks as coordinators may support robust institutional interest, but investors should await further disclosures for confirmation [[3]].

Deal Parties and Offering Structure

High-profile financial institutions have been engaged to support and execute the offering:

  • Overall Coordinators:
    • CMB International Capital Limited
    • BOCI Asia Limited
    • Shenwan Hongyuan Securities (H.K.) Limited
  • Underwriters/Sponsors: Names provided above; further appointments to be announced as per the listing rules.

Stabilization/over-allotment (greenshoe) details have not been disclosed. The caliber of deal parties involved may help underpin listing-day support, but this is inferred from the reputations and roles stated in the announcement [[3]].

Company Overview: Business Model, Products, and Leadership

Beijing Haizhi Technology Group Co., Ltd. operates as a joint stock company incorporated in China with limited liability. The company is positioned within the technology sector.

  • Business Model & Revenue Streams: Not detailed in the available announcement.
  • Key Products/Services: Not specified.
  • Customer Segments and Geographies: Not specified.
  • Industry/Sector Definition and Size: Not disclosed.

Board of Directors and Management:

Name Role
Mr. Ren Xuyang Chairman of the Board and Executive Director
Mr. Yang Zaifei Executive Director
Ms. Yang Juan Executive Director
Mr. Wan Pengjiang Executive Director
Mr. Li Jiaqing Non-Executive Director
Ms. Long Yu Non-Executive Director
Mr. Li Hongtao Non-Executive Director
Mr. Zhang Yifan Proposed Independent Non-Executive Director
Mr. Jiang Tian Proposed Independent Non-Executive Director
Mr. Li Shu Pai Proposed Independent Non-Executive Director
Mr. Ma Yeming Proposed Independent Non-Executive Director

Note: Backgrounds and experience of management team members are not detailed in the announcement [[3]].

Financial Health and Performance

No financial figures—such as revenue, profit, margins, cash flow, or debt—are disclosed in the current document. Investors should await the registered prospectus for comprehensive financial statements and historical performance analysis.

Market Position and Competitive Advantages

Market share, competitive advantages, brand strength, and industry ranking have not been disclosed. Details on monetization, customer concentration, or geographic breakdown are also not available in the announcement.

Industry Trends, Timing, and Market Environment

Sector and macroeconomic trends, as well as any recent company or industry developments, are not discussed in the announcement. The absence of concrete dates for the offer period, subscription window, or listing day highlights that investors should monitor further updates for timing and market condition assessments [[3]].

Key Risk Factors

The company’s announcement includes broad cautionary statements, emphasizing:

  • No guarantee of listing approval or offering completion.
  • No inducement to subscribe or purchase securities through this announcement.
  • Distribution restrictions: The securities are not registered for sale in the United States or other jurisdictions where such offerings are unlawful.
  • Legal and regulatory restrictions on dissemination of information.

Quantitative or specific risk exposures (e.g., customer concentration, supply chain, FX, product/geographic risk, related-party transactions) have not been disclosed [[1]][[2]][[3]].

Growth Strategy and Use of Proceeds

Concrete plans for expansion, new products, acquisitions, or capital expenditures are not described in the available announcement. Similarly, the intended use of offer proceeds has not been detailed.

Ownership Structure and Lock-up Arrangements

Pre- and post-IPO shareholdings, major shareholder identities, lock-in periods, and ESOPs are not disclosed in the current announcement.

Valuation and Peer Comparison

No figures for P/E, P/B, EV/EBITDA, revenue growth, net margin, ROE, ROA, or dividend yield for the company or its peers have been disclosed. No peer companies or sector performance tables are included.

No other IPOs or sector performance figures are cited in the announcement.

Research Coverage and Analyst Opinions

No analysts, covering institutions, price targets, or explicit opinions are stated in the document.

IPO Allotment Result

Final subscription outcomes, oversubscription metrics, and allocation implications are not included in the current information.

Listing Outlook and First-Day Prospects

Based solely on the information disclosed:

  • The IPO status remains preliminary, with no guarantee that listing or offering will proceed.
  • The engagement of reputable coordinators suggests institutional-grade execution, which may support listing-day performance if the offering moves forward.
  • All investment decisions should be made after reviewing the final, registered prospectus.

As key financials, offer terms, and demand metrics are not yet available, an informed estimate of the likely first-day trading range or outlook cannot be provided at this stage.

How to Access the Prospectus

The prospectus will be available on the official website of the Stock Exchange of Hong Kong: www.hkexnews.hk

Public Policy Holding Company, Inc. (PPHC) – Global Strategic Communications Leader | Financials, Growth Strategy & Acquisitions 2025

Public Policy Holding Company, Inc. (PPHC) – 2026 US IPO Deep Dive: Strategic Communications Giant Seeks US Listing Company Name: Public Policy Holding Company, Inc. Date of Prospectus: January 20, 2026 Public Policy Holding...

Shanghai Iluvatar CoreX Semiconductor: Leading China’s GPGPU & AI Computing Solutions – IPO, Technology, and Market Insights

Shanghai Iluvatar CoreX Semiconductor Co., Ltd. IPO Analysis – December 2025 Shanghai Iluvatar CoreX Semiconductor Co., Ltd. Date of Prospectus: December 30, 2025 Shanghai Iluvatar CoreX IPO: Ambitious AI Chipmaker Targets Hong Kong Listing...

How Insilico Medicine’s Pharma.AI Platform Is Revolutionizing Drug Discovery With Generative AI (2025)

Insilico IPO Analysis: In-Depth Investor Guide for 2025 Hong Kong Listing Insilico Date of Prospectus: December 18, 2025 Insilico’s Hong Kong IPO: Deep Dive Analysis, Key Metrics, and Investor Outlook for 2025 Insilico (Stock...